Skip to content

Study to evaluate tACS treatment to improve recovery in patients with schizophrenia

Modulating self-referential and interoceptive processing using transcranial alternating current stimulation (tACS): An open-label study to enhance recovery in schizophrenia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077652
Enrollment
20
Registered
2024-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: Transcranial alternating current stimulation: A 4x1 montage will be used with 2 mA current being delivered at the central F3 location. The peripheral 4 electrodes will get 25% (0.5mA) c

Sponsors

National Institute of Mental Health and Neurosciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of psychotic disorder as per International Classification of Diseases 10 at least as minimal sociooccupational dysfunction SOFAS more than 20. On a stable medication for the last 6 weeks with no major functionality in this 6 week period Providing written informed consent only patients with intact capacity to consent will be approached

Exclusion criteria

Exclusion criteria: Features suggestive of risk of harm to self (for example: suicidal risk, catatonia, prolonged nutritional deprivation) or others (for example: aggression or excitement) Need for Electroconvulsive therapy Recent history of antibiotic usage within the past 6 weeks Co-existing inflammatory bowel disease Co-morbid substance dependence (except caffeine and nicotine) Any significant medical or neurological disorder or condition affecting auditory, visual or any sensory modalities which remain uncorrected Any local skin lesion near the site of stimulation or any other contraindication to tACS.

Design outcomes

Primary

MeasureTime frame
Social and occupational functioningTimepoint: 6 week

Secondary

MeasureTime frame
heart rate variability markers electrogastrography markers Electroencephalography markers self-referential processing Psychopathology rating scoresTimepoint: change from before tACS to 2 days and 6 weeks after tACS

Countries

India

Contacts

Public ContactDr. Sreeraj V S

National Institute of Mental Health and Neurosciences (NIMHANS)

vs8sreeraj@yahoo.com09902597697

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026